Literature DB >> 10630762

Deep venous thrombosis of the arm after intravenous immunoglobulin infusion: case report and literature review of intravenous immunoglobulin-related thrombotic complications.

R S Go1, T G Call.   

Abstract

Thrombosis resulting from intravenous immunoglobulin infusion is a relatively unknown complication. We describe a patient who developed deep venous thrombosis of her left arm shortly after intravenous immunoglobulin administration. In addition, we review the thrombotic incidences reported in the literature and the possible association with hepatic veno-occlusive disease after bone marrow transplantation. Measures that can potentially prevent this complication are discussed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10630762     DOI: 10.4065/75.1.83

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  10 in total

1.  Pulmonary embolism after intravenous immunoglobulin.

Authors:  C Alliot; J P Rapin; M Besson; F Bedjaoui; D Messouak
Journal:  J R Soc Med       Date:  2001-04       Impact factor: 5.344

Review 2.  Intravenous immunoglobulin: adverse effects and safe administration.

Authors:  Hedi Orbach; Uriel Katz; Yaniv Sherer; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2005-12       Impact factor: 8.667

Review 3.  [Intravenous immunoglobulins in chronic idiopathic myositis].

Authors:  H Michels; G-R Burmester; F Buttgereit
Journal:  Z Rheumatol       Date:  2005-03       Impact factor: 1.372

Review 4.  Acute dermatomyositis with subcutaneous generalized edema.

Authors:  Gláucio R Werner de Castro; Simone Appenzeller; Manoel B Bértolo; Lílian T L Costallat
Journal:  Clin Rheumatol       Date:  2006-08-22       Impact factor: 2.980

Review 5.  Adverse effects of treatment with intravenous immunoglobulins for neurological diseases.

Authors:  Matthias Wittstock; Uwe K Zettl
Journal:  J Neurol       Date:  2006-09       Impact factor: 4.849

Review 6.  Sensitized renal transplant recipients: current protocols and future directions.

Authors:  James Gloor; Mark D Stegall
Journal:  Nat Rev Nephrol       Date:  2010-03-16       Impact factor: 28.314

7.  Single-dose intravenous gammaglobulin can stabilize neutrophil Mac-1 activation in sickle cell pain crisis.

Authors:  Deepa Manwani; Grace Chen; Veronica Carullo; Stelian Serban; Olugbenga Olowokure; Jungeun Jang; Matthew Huggins; Hillel W Cohen; Henny Billett; George F Atweh; Paul S Frenette; Patricia A Shi
Journal:  Am J Hematol       Date:  2015-04-01       Impact factor: 10.047

Review 8.  Intravenous immunoglobulin in lupus panniculitis.

Authors:  João Espírito Santo; M F Gomes; M J Gomes; L Peixoto; S C Pereira; A Acabado; J Freitas; G Vinhas de Sousa
Journal:  Clin Rev Allergy Immunol       Date:  2010-04       Impact factor: 8.667

Review 9.  On the dark side of therapies with immunoglobulin concentrates: the adverse events.

Authors:  Peter J Späth; Guido Granata; Fabiola La Marra; Taco W Kuijpers; Isabella Quinti
Journal:  Front Immunol       Date:  2015-02-05       Impact factor: 7.561

10.  Appropriateness of the use of intravenous immune globulin before and after the introduction of a utilization control program.

Authors:  Thomas E Feasby; Hude Quan; Michelle Tubman; David Pi; Alan Tinmouth; Lawrence So; William A Ghali
Journal:  Open Med       Date:  2012-03-13
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.